RxDoctor Payments Data

Susan Gonzalez

Psychiatric/Mental Health · Saint Paul, MNNPI 1457506677

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 27 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 13.5% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in MN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$422in general payments, 2019–2025

Across 27 payments — averaging $15.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$57
  • Neuronetics, Inc.$49
  • Almatica Pharma LLC$41
  • Corium, LLC$36
  • Vanda Pharmaceuticals Inc.$30
  • Lundbeck LLC$30
  • plus $179 from 10 others

What the payments were for

  • Food & beverage$422100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$422 in reported general payments places this provider in the 90th percentile of 407 psychiatric/mental health providers in Minnesota.

See all psychiatric/mental health providers in Minnesota

Medicare billing

Part B allowed, 2024
$12,534
Medicare patients
38
Services billed
112

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate13$46,834
LybalviOlanzapine/Samidorphan Malate11$17,951
Risperdal ConstaRisperidone Microspheres21$13,371
Olanzapine49$3,486
Hydroxyzine Hcl79$2,893
Paliperidone ErPaliperidone14$2,523
Quetiapine Fumarate89$2,206
Desvenlafaxine Succinate ErDesvenlafaxine Succinate48$2,160
Bupropion XlBupropion Hcl86$2,149
Gabapentin58$1,972
Nortriptyline Hcl26$1,629
Fluoxetine Hcl89$1,407
Lurasidone Hcl16$1,404
Duloxetine Hcl65$1,368
Aripiprazole76$1,305

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Risperdal Consta$30$60,20534 claims
Alkermes, Inc.Lybalvi$15$17,95111 claims
Almatica Pharma LLCSertraline Hcl$41$41734 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 407 psychiatric/mental health providers in Minnesota.

Other psychiatric/mental health in Saint Paul

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →